Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05147558 |
|---|---|
| Brief Title: | A Study of Pembrolizumab With Lenvatinib in Women With Advanced Uterine Carcinosarcoma |
| First Submitted : | November 15, 2021 |
| First Submitted that Met QC Criteria : | December 6, 2021 |
| First Posted : | December 7, 2021 |
| Last Update Submitted that Met QC Criteria : | April 27, 2022 |
| Last Update Posted : | May 3, 2022 |